These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 6305295

  • 1. Disease due to cytomegalovirus and its long-term consequences in renal transplant recipients. Correlation of allograft survival with disease due to cytomegalovirus and rubella antibody level.
    Luby JP, Ware AJ, Hull AR, Helderman JH, Gailiunas P, Butler S, Atkins C.
    Arch Intern Med; 1983 Jun; 143(6):1126-9. PubMed ID: 6305295
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
    Marker SC, Howard RJ, Simmons RL, Kalis JM, Connelly DP, Najarian JS, Balfour HH.
    Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
    Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL.
    Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
    [Abstract] [Full Text] [Related]

  • 4. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarrett RF, Madeley CR.
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [Abstract] [Full Text] [Related]

  • 5. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Apr; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 8. The problem of cytomegalovirus infection in renal allograft recipients.
    Kurtz JB, Thompson JF, Ting A, Pinto A, Morris PJ.
    Q J Med; 1984 Mar; 53(211):341-9. PubMed ID: 6091169
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.
    John GT, Manivannan J, Chandy S, Peter S, Fleming DH, Chandy SJ, Balakrishnan N, Krishnamurthy K, Kirubakaran MG, Jacob CK.
    Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.
    Simmons RL, Matas AJ, Rattazzi LC, Balfour HH, Howard JR, Najarian JS.
    Surgery; 1977 Nov; 82(5):537-46. PubMed ID: 199956
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R.
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [Abstract] [Full Text] [Related]

  • 14. Rubella antibodies and adverse events late after renal transplantation.
    Luby JP, Ware AJ, Vergne-Marini P, Stastny P, Hull AR.
    Arch Intern Med; 1979 Jan; 139(1):33-5. PubMed ID: 367306
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 16. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K, Treska V.
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [Abstract] [Full Text] [Related]

  • 17. [Relation between cytomegalovirus infection and the so-called intolerance to azathioprine in renal transplantation].
    Ancona G, Dean P, Muolo A, Galvani E, Zanuso C, Gulino S, Confortini P.
    Minerva Chir; 1980 May 31; 35(10):731-4. PubMed ID: 6256686
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 31; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 19. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY, Ho KN, Yuen KY, Lui SL, Li FK, Chan TM, Lo WK, Cheng IK.
    Clin Transplant; 1997 Aug 31; 11(4):286-93. PubMed ID: 9267717
    [Abstract] [Full Text] [Related]

  • 20. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
    Boobes Y, Al Hakim M, Dastoor H, Bernieh B, Abdulkhalik S.
    Transplant Proc; 2004 Aug 31; 36(6):1841-3. PubMed ID: 15350493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.